4.5 Article

Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus

Journal

BMC PREGNANCY AND CHILDBIRTH
Volume 13, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1471-2393-13-119

Keywords

Hepatitis B virus; Mother-to-child transmission; Vaginal delivery; Caesarean section

Funding

  1. National Key Basic Research Project (973 Planning), China [2010CB945104]
  2. Department of Health, Jiangsu Province [XK201102]
  3. Nanjing Medical Science and Technique Development Foundation, Nanjing, China [2011024]

Ask authors/readers for more resources

Background: Many clinicians and hepatitis B virus (HBV)-infected pregnant women prefer elective caesarean section (ECS) to prevent mother-to-child transmission of HBV, since some studies found higher transmission of HBV in infants born by vaginal delivery (VD) than by cesarean section. However, other studies showed that ECS does not reduce the risk of being infected with HBV in infants. In this study, we aimed to clarify whether ECS may reduce the risk of mother-to-child transmission of HBV. Methods: Totally 546 children (1-7-year-old) born to 544 HBsAg-positive mothers from 15 cities and rural areas across Jiangsu Province, China, were enrolled. Of these children, 137 (2 pairs of twins) were born to HBeAg-positive mothers; 285 were delivered by ECS and 261 others by VD (one pair of twin in each group). HBV serologic markers were tested by enzyme or microparticle immunoassay. Results: The maternal and gestational ages, maternal HBeAg-positive rates, and children's ages, gender ratios, hepatitis B vaccine coverage and administrations of HBIG were comparable between ECS and VD groups (all p > 0.05). The overall prevalence of HBsAg in the 546 children was 2.4%, with 2.5% (7/285) and 2.3% (6/261) in those born by ECS and VD respectively (p = 0.904). Further comparison of chronic HBV infection in the 137 children of HBeAg-positive mothers showed that the HBsAg-positive rates in ECS and VD groups were 10.3% (7/68) and 8.7% (6/69) respectively (p = 0.750), while the mothers had similar HBV DNA levels (2.38 x 10(6) vs. 2.35 x 10(6) IU/ml, p = 0.586). Additionally, the overall rate of anti-HBs >= 10 mIU/ml in the children was 71.6%, with 72.3% and 70.9% in those born by ECS and VD respectively (p = 0.717). Conclusions: With the recommended immunoprophylaxis against hepatitis B, ECS does not reduce the risk of mother-to-child transmission of HBV. Therefore, ECS should not be used in HBsAg-positive pregnant women to prevent mother-to-child transmission of HBV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available